Vor bio to participate in the wedbush pacgrow healthcare conference

Cambridge, mass., aug. 01, 2023 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 wedbush pacgrow healthcare conference.

VOR Ratings Summary

VOR Quant Ranking